GlassScriptPhysician profile
Cataldo Doria
NPI 1255357877
$20,219.74
in general payments reported to CMS, 2019-2025
12 companies · $4,851 in 2025
The $4,851 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $171 · 2021: $124 · 2022: $37.40 · 2023: $59.40 · 2024: $186 · 2025: $4,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,865 · Food and Beverage: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,865.48 |
| Food and Beverage | $1,231.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $12,849.44 | 2019 | |
| Histosonics, INC. | $2,710.65 | 2025 | |
| Medtronic, INC. | $1,879.12 | 2025 | Signia |
| Intuitive Surgical, INC. | $1,771.51 | 2019-2020 | |
| Ethicon US, LLC | $385.69 | 2019-2022 | |
| Pharmacosmos Therapeutics INC. | $186.17 | 2024 | Monoferric |
| Integra Lifesciences Corporation | $158.12 | 2020-2023 | Codman Certas, Duraseal Exact Spinal Sealant System, Codman Hakim |
| Abbvie INC. | $125.00 | 2025 | |
| Daiichi Sankyo INC. | $119.41 | 2025 | Enhertu |
| Roche Diagnostics Corporation | $17.50 | 2020 | |
| Ambu INC. | $17.13 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cataldo Doria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.